Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of BurstDR and Tonic Spinal Cord Stimulation (SCS) on Glucose Metabolism in Patients With Neuropathic Pain

NCT05794776 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05794776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of BurstDR and Tonic Spinal Cord Stimulation (SCS) on Glucose Metabolism in Patients With Neuropathic Pain
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Withdrawn
Start date
March 16, 2023
Completion date
October 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin secretion, spinal cord stimulation